큐프리나 홀딩스(CUPR)는 NASDAQ에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $1.78 (+2.89%), 시가총액 $0.01B, 52주 최저~최고 $0.25 ~ $9.40.
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidi
큐프리나 홀딩스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
큐프리나 홀딩스의 현재 주가는 $1.78 (+2.89%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
큐프리나 홀딩스의 시가총액은 약 $0.01B입니다.
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures a